Title of article
Galactose-PEG dual conjugation of β-(1→3)-d-glucan schizophyllan for antisense oligonucleotides delivery to enhance the cellular uptake
Author/Authors
Ryouji Karinaga، نويسنده , , Takahisa Anada، نويسنده , , Jusaku Minari، نويسنده , , Masami Mizu، نويسنده , , Kazuya Koumoto، نويسنده , , Junji Fukuda، نويسنده , , Kohji Nakazawa، نويسنده , , Teruaki Hasegawa، نويسنده , , Munenori Numata، نويسنده , , Seiji Shinkai، نويسنده , , Kazuo Sakurai، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2006
Pages
10
From page
1626
To page
1635
Abstract
Antisense oligonucleotides (AS ODNs) are applied to silence a particular gene, and this approach is one of the potential gene therapies. However, naked oligonucleotides are easy to be degraded or absorbed in biological condition. Therefore, we need a carrier to deliver AS ODNs. This paper presents galactose moieties that were conjugated to the side chain of SPG to enhance cellular ingestion through endocytosis mediated by asialoglycoprotein receptor specifically located on parenchymal liver cells. We introduced galactose with two types of chemical bonds; amide and amine, and the amine connection showed lower ingestion and more toxicity than the amide one. Since PEG was known to induce endocytosis escape, we combined PEG and galactose aiming to provide both cellular up-take and subsequent endocytosis escape. We designed lactose or galactose moieties to attach to the end of the PEG chain that connects to the SPG side chain. When the PEG had the molecular weight of 5000–6000, the antisense effect reached the maximum. We believe that this new type of galactose and PEG dual conjugation broaden the horizon in antisense delivery.
Keywords
Hepatocyte , antisense , Polysaccharide , gene transfer
Journal title
Biomaterials
Serial Year
2006
Journal title
Biomaterials
Record number
546799
Link To Document